CPAMS has been provided in New Zealand for 10 years
- Currently over 6000 patients are using the service
- Over 10,000 patients have been treated over the last 5 years.
- Over 160 pharmacies provide the service.
Anticoagulant control
- Control is measured by assessing the time within the therapeutic range (TTR). A TTR greater than 60% is regarded as “good” control.
- The TTR for the whole CPAMS population was 73%
- Control has remained stable over the last 5 years.
- Approximately 80% of patients achieve good control (TTR>60%).
- The risk of bleeding is associated with a high INR result.
- Only 2% of INR results were greater than 4.5
- Only 0.02% of INR results were greater than 8.0
Conclusion
- CPAMS provides an efficient safe anticoagulant monitoring service giving a consistent high level of anticoagulant control. There is scope to expand the service which could become the standard of care for warfarin management in New Zealand.
See full CPAMS at 10 Report
